Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(12)
•••
ZoranSto
X
View Profile
View Bullboard History
Comment by
ZoranSto
on Jun 20, 2024 2:33pm
RE:RE:Horrific value destruction
It will be voting time again and I think Oats is pissed as well so maybe this vote we will be able to make some changes. And as usual not one insider buy....
(150)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Jun 20, 2024 12:14pm
RE:Horrific value destruction
Honestly ZoranSto do you expect anything less from gagnon, After all as proph pointed out, this stock was once at $300US plus and getting it were it is today takes a special type of talent to ensure
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(12)
•••
ZoranSto
X
View Profile
View Bullboard History
Post by
ZoranSto
on Jun 20, 2024 10:45am
Horrific value destruction
This has been dropping constantly for the past couple of weeks and absolutley no comments from Gilles......what is going on?????
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 19, 2024 9:48am
RE:RE:Safety/tolerability profile
CZO mentioned that it also combined avenanthramide with one of its newer PGX carriers with promising results. The current pill trial may be a building block to greater things as PGX also reaches the
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 19, 2024 9:09am
RE:Safety/tolerability profile
We've never seen any preclinical data for the avenanthramide pill formulation or much of an explaination of what exactly it is. It is a mystery. Do they have preclinical data supporting a
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 19, 2024 8:43am
Safety/tolerability profile
It's been three weeks as of today since CZO reported its Q1 results and that all single dose levels of the avenanthramide pill to 960mg had been administered without a serious adverse event. These
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 18, 2024 2:24pm
AGM materials
Perplexity Ai: "NASDAQ requires that proxy materials be distributed to shareholders at least 20 calendar days prior to the shareholder meeting date. TSX requires that proxy materials be
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 18, 2024 1:05pm
What's the final shares outstanding?
It's now been over two weeks since the merger closed. What is the final count for the shares outstanding? How many of the AEZS warrants were ultimately exercised?
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 17, 2024 10:38pm
Perplexity Ai on what we can expect...
Based on the information provided, we can expect the following regarding the scientific publication in the journal Biomaterials: A comprehensive scientific article was recently submitted to the
...more
(150)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 17, 2024 2:59pm
Re: - Paediatric Data and Licensing Deal
Thank you for pointing this out - What did AEZS's stock do the last time there was a licensing deal alone for its diagnostic test with pediatric data still in the future? From a close of $259
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 16, 2024 10:33pm
AEZS's previous pediatric diagnostic trial:
Horm Res Paediatr . 2021;94(7-8):239-250
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 16, 2024 11:14am
Pediatric data and licensing deal
There are only about 4 million shares, I believe, and the stock is currently trading around the value of its cash so it will be interesting to see how this illiquid stock reacts to significant news
...more
(150)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jun 15, 2024 1:45am
Re: How to launch a new company
Well another failure can be contributed to gagnon, the Nasdqa has has five records highs of in a row, meanwhile the new AEZS looks like quadruple black diamond run and steep at that, down, down, and
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 14, 2024 9:26am
How to launch a company
It's been ten days since the merger closed. There are only 32 days or 22 business days until the AGM. The proposed new name for the company should be released soon. Until we see a detailed plan
...more
(2019)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jun 13, 2024 9:56pm
RE:New Press Release - Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders
There's a strong case here that CEAPRO's management did not act in shareholder's best interest in this merger. A class action lawsuit would be needed before the directors resign (usually
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >